RFS rate and NNT per additional recurrence-free survivor
Using the pooled patient data, the weighted RFS curves for nivolumab, placebo, and ipilimumab, were estimated using the Nelson-Aalen estimator [NNT represents the number of patients who needed to be treated with a treatment compared with another treatment to obtain one additional beneficial outcome [